Maria A. Solinis - Publications

Nanomedicines for DNA and interference RNA co-delivery: Combined gene therapy for Fabry disease.

Journal: International journal of pharmaceutics: X

Published: December 19, 2025

Patients' and community pharmacists' perceptions of a new service for medicines subject to additional monitoring.

Journal: The International journal of pharmacy practice

Published: April 01, 2025

Impact of Additional Monitoring on Pharmacovigilance and Pharmacists' Role: A Scoping Review.

Journal: Pharmacoepidemiology and drug safety

Published: March 07, 2025

Asialofetuin-Coupled Lipid-Based nanosystems to target the Asialoglycoprotein receptor: Delivering genes to hepatocytes for the treatment of Fabry disease.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: January 31, 2025

Clinical efficacy, safety and pharmacokinetics of novel β-lactam/β-lactamase inhibitor combinations: a systematic review.

Journal: JAC-antimicrobial resistance

Published: January 21, 2025

Cationic Green Solid Lipid nanoparticles by the fatty acid coacervation method for gene delivery to the cornea: preliminary studies on cell and isolated tissue models.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

Published: January 11, 2025

Population pharmacokinetics of oral fosfomycin calcium in healthy women.

Journal: The Journal of antimicrobial chemotherapy

Published: May 14, 2024

Outcomes of Community Pharmacy Interventions on Patients with Medicines Under Additional Monitoring.

Journal: Integrated pharmacy research & practice

Published: May 09, 2024

Optimizing Antibiotic Therapy for Stenotrophomonas maltophilia Infections in Critically Ill Patients: A Pharmacokinetic/Pharmacodynamic Approach.

Journal: Antibiotics (Basel, Switzerland)

Published: May 08, 2024

Targeting strategies with lipid vectors for nucleic acid supplementation therapy in Fabry disease: a systematic review.

Journal: Drug delivery and translational research

Published: March 18, 2024

Does selective digestive decontamination (SDD) increase antibiotic resistance? Long-term comparison of two intensive care units (with and without SDD) of the same tertiary hospital.

Journal: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology

Published: September 27, 2023

Novel Golden Lipid Nanoparticles with Small Interference Ribonucleic Acid for Substrate Reduction Therapy in Fabry Disease.

Journal: Pharmaceutics

Published: June 07, 2023